NCT05348356
A Phase 2 trial of Nirogacestat in Patients with Recurrent Ovarian Granulosa
Cell Tumors
Cell Tumors
Associated Conditions
Ovarian, Fallopian, or Primary Peritoneum CancerPrincipal Investigator
Robert Holloway
Sponsor
SpringWorks Therapeutics
You are being asked to take part in a clinical research study because you have a rare type of ovarian cancer known as ovarian granulosa cell tumor (also known as sex cord-stromal tumor). A person who takes part in a research study is called a research participant.